Abstract
Chronic pulmonary Aspergillosis (CPA) refers to chronic pulmonary Aspergillus infection, and the duration of CPA is usually more than 3 months, CPA occurs in patients with underlying lung disease or mild immunosuppression and needs relatively long treatment duration.In recent years, the clinician′s understanding of the disease is more and more improved.The Infectious Diseases Society of America (IDSA) has presented the consensus of the treatment of aspergillosis in 2000, and was updated in 2008.In addition, there is no CPA published clinical guidelines.Recently, an expert group from the European Society of Clinical Microbiology and Infection Diseases (ESCMID) and from the European Respiratory Society (ERS) summarized the results of preliminary research on CPA, and released a rationale and clinical guideline of CPA.This article is a review of the latest progress of diagnosis and treatment of CPA. Key words: Pulmonary aspergillosis, chronic; Diagnosis; Treatment
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
